the cpn10 to use in the current trial came from a storage facility in the US.
"Stocks of INV103 (Cpn10) have been transferred to Laureate Biopharmaceutical Services USA (Princeton, NJ) where they will be tested (qualified), formulated and filled for release to support a proof-of-concept clinical trial in lupus." 2012 release
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.010(8.00%) |
Mkt cap ! $10.59M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.5¢ | 12.5¢ | $13.37K | 99.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1031 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 11534 | 2 |
View Market Depth
| Last trade - 10.17am 23/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |